Conecte-se

Bibliografias temáticas / Interleukin-12 / Artigos de revistas

Siga este link para ver outros tipos de publicações sobre o tema: Interleukin-12.

Artigos de revistas sobre o tema "Interleukin-12"

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 25 de julho de 2025

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Interleukin-12".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

Leonard, Patricia, and Sanjiv Sur. "Interleukin-12." BioDrugs 17, no. 1 (2003): 1–7. http://dx.doi.org/10.2165/00063030-200317010-00001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

&NA;. "Interleukin-12." Inpharma Weekly &NA;, no. 1124 (1998): 7. http://dx.doi.org/10.2165/00128413-199811240-00013.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Trinchieri, Giorgio. "Interleukin-12." Clinical Immunotherapeutics 3, no. 4 (1995): 262–70. http://dx.doi.org/10.1007/bf03259278.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Clinton, Steven K., Eduardo Canto, and Michael A. O'Donnell. "INTERLEUKIN-12." Urologic Clinics of North America 27, no. 1 (2000): 147–55. http://dx.doi.org/10.1016/s0094-0143(05)70242-1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Weiner, David. "Plasmid Interleukin 12." AIDS 14, no. 12 (2000): 1759–60. http://dx.doi.org/10.1097/00002030-200008180-00010.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Leng, S. X., and J. A. Elias. "Interleukin-11 inhibits macrophage interleukin-12 production." Journal of Immunology 159, no. 5 (1997): 2161–68. http://dx.doi.org/10.4049/jimmunol.159.5.2161.

Texto completo da fonte

Resumo:

Abstract IL-12 is a heterodimeric cytokine produced by phagocytic and other cells with important physiologic and pathologic properties. Regulated IL-12 production is crucial for the generation of protective Th1 responses to infectious agents. In contrast, IL-12 excess contributes to the pathogenesis of a variety of autoimmune and inflammatory disorders. To further understand the processes regulating IL-12 production, we determined whether IL-11 regulated monocyte/macrophage production of this cytokine moiety. IL-11 did not alter the IL-12 (p70) production of unstimulated THP-1 monocytic cells

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Fox, Robert J., and Abdolmohamad M. Rostami. "Anti???Interleukin-12 Antibody." BioDrugs 13, no. 4 (2000): 233–41. http://dx.doi.org/10.2165/00063030-200013040-00002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

&NA;. "Interleukin-12 trial halted." Reactions Weekly &NA;, no. 556 (1995): 2. http://dx.doi.org/10.2165/00128415-199505560-00003.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

&NA;. "Interleukin-12 studies continue." Reactions Weekly &NA;, no. 558 (1995): 2. http://dx.doi.org/10.2165/00128415-199505580-00003.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

&NA;. "Interleukin-12 trial halted." Inpharma Weekly &NA;, no. 992 (1995): 21. http://dx.doi.org/10.2165/00128413-199509920-00047.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

&NA;. "Interleukin-12 studies continue." Inpharma Weekly &NA;, no. 994 (1995): 21. http://dx.doi.org/10.2165/00128413-199509940-00042.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

KATIYAR, S. "Interleukin-12 and photocarcinogenesis." Toxicology and Applied Pharmacology 224, no. 3 (2007): 220–27. http://dx.doi.org/10.1016/j.taap.2006.11.017.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Maguire, H. C. "INTERLEUKIN 12 AS IMMUNOADJUVANT." Journal of Immunotherapy 16, no. 3 (1994): 240. http://dx.doi.org/10.1097/00002371-199410000-00032.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

de Rie, M. A. "Interleukin 12 and Psoriasis." Dermatology 199, no. 2 (1999): 101. http://dx.doi.org/10.1159/000018213.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Trinchieri, Giorgio, and Franca Gerosa. "Immunoregulation by interleukin-12." Journal of Leukocyte Biology 59, no. 4 (1996): 505–11. http://dx.doi.org/10.1002/jlb.59.4.505.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Ma, X., A. D'Andrea, M. Kubin, et al. "Production of interleukin-12." Research in Immunology 146, no. 7-8 (1995): 432–38. http://dx.doi.org/10.1016/0923-2494(96)83012-4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Crutcher, J. M., M. M. Stevenson, M. Sedegah, and S. L. Hoffman. "Interleukin-12 and malaria." Research in Immunology 146, no. 7-8 (1995): 552–59. http://dx.doi.org/10.1016/0923-2494(96)83031-8.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Tsai, I. San, Chi-Cheng Tsai, Ya-Ping Ho, Kun-Yen Ho, Yi-Min Wu, and Chun-Cheng Hung. "Interleukin-12 and interleukin-16 in periodontal disease." Cytokine 31, no. 1 (2005): 34–40. http://dx.doi.org/10.1016/j.cyto.2005.02.007.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

BACON, CHRIS M., SARAH S. CHO, and JOHN J. O'SHEA. "Signal Transduction by Interleukin-12 and Interleukin-2." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 41–59. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52654.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Torti, Dorothea C., and Steven R. Feldman. "Interleukin-12, interleukin-23, and psoriasis: Current prospects." Journal of the American Academy of Dermatology 57, no. 6 (2007): 1059–68. http://dx.doi.org/10.1016/j.jaad.2007.07.016.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Sánchez, E., S. Morales, L. Paco, et al. "Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus." Rheumatology 44, no. 9 (2005): 1136–39. http://dx.doi.org/10.1093/rheumatology/keh697.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Orozco, Gisela, Miguel A. González-Gay, Laura Paco, et al. "Interleukin 12 (IL12B) and Interleukin 12 Receptor (IL12RB1) Gene Polymorphisms in Rheumatoid Arthritis." Human Immunology 66, no. 6 (2005): 710–14. http://dx.doi.org/10.1016/j.humimm.2005.02.004.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Mattner, Frank, Susanne Fischer, Stefanie Guckes, et al. "The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer." European Journal of Immunology 23, no. 9 (1993): 2202–8. http://dx.doi.org/10.1002/eji.1830230923.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Eman, Arif Rahman, Vitayani Muchtar Sri, Tabri Farida, et al. "EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY." International Journal of Medical Reviews and Case Reports 2, no. 4 (2018): 161–65. https://doi.org/10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS.

Texto completo da fonte

Resumo:

Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae. In leprosy, cell-mediated immune responses are an important aspect of host resistance to mycobacterial infections and allegedly governed by anequilibrium between type 1 cytokines including Interleukin-12 (IL-12); with type 2 cytokines such as Interleukin-4 (IL-4). Currently, the World Health Organization (WHO) recommends 3 leprosy treatment regimens, one of them is Rifampicin Ofloxacin Minocycline (ROM). To date, studies on the effects of ROM on leprosy have been limited, none have specifically assessed the eff

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Lu, Zhiyu, Keye Xu, Xiaoying Wang, Yan Li, and Mingcai Li. "Interleukin 39: a new member of interleukin 12 family." Central European Journal of Immunology 45, no. 2 (2020): 214–17. http://dx.doi.org/10.5114/ceji.2020.97911.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Rentzos, M., C. Nikolaou, E. Andreadou, et al. "Circulating interleukin-10 and interleukin-12 in Parkinson’s disease." Acta Neurologica Scandinavica 119, no. 5 (2009): 332–37. http://dx.doi.org/10.1111/j.1600-0404.2008.01103.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Tahara, H., L. Zitvogel, W. J. Storkus, T. G. McKinney, P. D. Robbins, and M. T. Lotze. "CANCER GENE THERAPY USING INTERLEUKIN-12 (IL-12)." Journal of Immunotherapy 16, no. 3 (1994): 245. http://dx.doi.org/10.1097/00002371-199410000-00053.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

&NA;. "Interleukin-12 toxicity mystery solved." Reactions Weekly &NA;, no. 580 (1995): 2. http://dx.doi.org/10.2165/00128415-199505800-00002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

&NA;. "Interleukin-12 toxicity mystery solved." Inpharma Weekly &NA;, no. 1016 (1995): 21. http://dx.doi.org/10.2165/00128413-199510160-00046.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Romani, L., P. Puccetti, and F. Bistoni. "Interleukin-12 in infectious diseases." Clinical Microbiology Reviews 10, no. 4 (1997): 611–36. http://dx.doi.org/10.1128/cmr.10.4.611.

Texto completo da fonte

Resumo:

Interleukin-12 (IL-12) is a potent immunoregulatory cytokine that is crucially involved in a wide range of infectious diseases. In several experimental models of bacterial, parasitic, viral, and fungal infection, endogenous IL-12 is required for early control of infection and for generation and perhaps maintenance of acquired protective immunity, directed by T helper type 1 (Th1) cells and mediated by phagocytes. Although the relative roles of IL-12 and gamma interferon in Th1-cell priming may be to a significant extent pathogen dependent, common to most infections is that IL-12 regulates the

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Romani, L., P. Puccetti, and F. Bistoni. "Interleukin-12 in infectious diseases." Clinical microbiology reviews 10, no. 4 (1997): 611–36. http://dx.doi.org/10.1128/cmr.10.4.611-636.1997.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Bashyam, Hema. "Interleukin-12: A master regulator." Journal of Experimental Medicine 204, no. 5 (2007): 969. http://dx.doi.org/10.1084/jem.2045fta.

Texto completo da fonte

Resumo:

Early resistance to pathogens requires a swift response from NK cells. In 1989, Giorgio Trinchieri identified an NK growth factor and activator, later called interleukin-12 (IL-12). This discovery helped reveal the regulatory link between innate and adaptive immunity.

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Adorini, Luciano. "Interleukin 12 and autoimmune diabetes." Nature Genetics 27, no. 2 (2001): 131–32. http://dx.doi.org/10.1038/84732.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Bubeník, Jan. "Interleukin 12 in Cancer Treatment." Folia Biologica 57, no. 1 (2011): 1–2. http://dx.doi.org/10.14712/fb2011057010001.

Texto completo da fonte

Resumo:

Interleukin 12 (IL-12) is made up of two disulphidelinked chains, p35 and p40. The cytokine is produced by monocytes, macrophages, myeloid dendritic cells and B cells. It stimulates development of NK cells and TH1 differentiation of CD4+ T cells, thus participating in the regulation of the immune response (for a review, see Klein and Hořejší, 1997; Grufman and Kärre, 2000; Jinushi and Tahara, 2009). Recently, the structurally similar but functionally different cytokine IL-23 displaying anti-tumour effects and related to the IL-12 family of cytokines was discovered (Engel and Neurath, 2010). In

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Sacks, G. P., D. Scott, H. Tivnann, T. Mire-Sluis, I. L. Sargent, and C. W. G. Redman. "Interleukin-12 and pre-eclampsia." Journal of Reproductive Immunology 34, no. 2 (1997): 155–58. http://dx.doi.org/10.1016/s0165-0378(97)00028-4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Bryan, Dani-Louise, Joanna S. Hawkes, and Robert A. Gibson. "Interleukin-12 in Human Milk." Pediatric Research 45, no. 6 (1999): 858–59. http://dx.doi.org/10.1203/00006450-199906000-00013.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Sturmhoefel, K., K. Lee, M. O. Toole, H. M. Swiniarski, A. J. Dorner, and S. F. Wolf(xc*). "Interleukin 12 as vaccine adjuvant." Research in Immunology 149, no. 1 (1998): 37–39. http://dx.doi.org/10.1016/s0923-2494(98)80041-2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Rowe, PaulM. "Cautious optimism over interleukin-12." Lancet 345, no. 8962 (1995): 1432. http://dx.doi.org/10.1016/s0140-6736(95)92618-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Trinchieri, Giorgio, Manthrasalam Rengaraju, Annalisa D'Andrea, et al. "Producer cells of interleukin-12." Immunology Today 14, no. 5 (1993): 237–38. http://dx.doi.org/10.1016/0167-5699(93)90173-i.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

MA, XIAOJING, MIGUEL ASTE-AMEZAGA, and GIORGIO TRINCHIERI. "Regulation of Interleukin-12 Production." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 13–25. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52651.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

BLISS, JUDY, RICHARD MAYLOR, KEYA STOKES, KRISTIN S. MURRAY, MARA A. KETCHUM, and STANLEY F. WOLF. "Interleukin-12 as Vaccine Adjuvant." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 26–35. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52652.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Podlaski, Frank J., Venkata B. Nanduri, Jeffrey D. Hulmes, et al. "Molecular characterization of interleukin 12." Archives of Biochemistry and Biophysics 294, no. 1 (1992): 230–37. http://dx.doi.org/10.1016/0003-9861(92)90162-p.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Trinchieri, Giorgio, Manthrasalam Rengaraju, Annalisa D'Andrea, et al. "Producer cells of interleukin 12." Parasitology Today 9, no. 3 (1993): 97. http://dx.doi.org/10.1016/0169-4758(93)90215-2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Brunda, Michael J., and Maurice K. Gately. "Antitumor Activity of Interleukin-12." Clinical Immunology and Immunopathology 71, no. 3 (1994): 253–55. http://dx.doi.org/10.1006/clin.1994.1081.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Karp, Christopher L. "Interleukin-12: Amiss in MS." Annals of Neurology 45, no. 6 (1999): 689–92. http://dx.doi.org/10.1002/1531-8249(199906)45:6<689::aid-ana1>3.0.co;2-m.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Gately, Maurice K., Louis M. Renzetti, Jeanne Magram, et al. "THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses." Annual Review of Immunology 16, no. 1 (1998): 495–521. http://dx.doi.org/10.1146/annurev.immunol.16.1.495.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Wang, Xin, Victoria L. Wilkinson, Frank J. Podlaski, et al. "Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits." European Journal of Immunology 29, no. 6 (1999): 2007–13. http://dx.doi.org/10.1002/(sici)1521-4141(199906)29:06<2007::aid-immu2007>3.0.co;2-0.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Yücel, Özlem Özer, Ezel Berker, Semra Gariboğlu та Harika Otlu. "Interleukin-11, interleukin-1β, interleukin-12 and the pathogenesis of inflammatory periodontal diseases". Journal of Clinical Periodontology 35, № 5 (2008): 365–70. http://dx.doi.org/10.1111/j.1600-051x.2008.01212.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

GATELY, MAURICE K., DAISY M. CARVAJAL, SUZANNE E. CONNAUGHTON, et al. "Interleukin-12 Antagonist Activity of Mouse Interleukin-12 p40 Homodimer in Vitro and in Vivo." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 1–12. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52650.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Robinson, Cory M., and Gerard J. Nau. "Interleukin‐12 and Interleukin‐27 Regulate Macrophage Control ofMycobacterium tuberculosis." Journal of Infectious Diseases 198, no. 3 (2008): 359–66. http://dx.doi.org/10.1086/589774.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!